Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ergoject is a Swiss medical device company that specializes in the design, development, and production of high-quality injection systems for intraocular lenses (IOLs). The company's primary focus is on providing innovative solutions for cataract surgery, enabling surgeons to implant artificial lenses through micro-incisions with high precision and safety. Ergoject offers a range of products, including single-use and reusable injectors, and often operates as an original equipment manufacturer (OEM) for global IOL producers. In December 2020, Ergoject was acquired by Haag-Streit, a prominent international medical technology group, to enhance its surgical ophthalmology portfolio. The company continues to operate from its headquarters in Luterbach, Switzerland, maintaining its reputation for Swiss engineering excellence in the ophthalmic field.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ergoject.